Real Brokerage [REAX] vs CBRE [CBRE] Detailed Stock Comparison
Real Brokerage
NASDAQ
Loading...
CBRE
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Real Brokerage wins in 6 metrics, CBRE wins in 12 metrics, with 0 ties. CBRE appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Real Brokerage | CBRE | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -28.43 | 48.64 | Real Brokerage |
| Price-to-Book Ratio | 25.50 | 5.67 | CBRE |
| Debt-to-Equity Ratio | 0.00 | 100.42 | Real Brokerage |
| PEG Ratio | -102.00 | 26.51 | Real Brokerage |
| EV/EBITDA | -61.35 | 22.79 | Real Brokerage |
| Profit Margin (TTM) | -1.09% | 2.74% | CBRE |
| Operating Margin (TTM) | -1.47% | 3.10% | CBRE |
| EBITDA Margin (TTM) | N/A | 3.10% | N/A |
| Return on Equity | -53.24% | 11.92% | CBRE |
| Return on Assets (TTM) | -10.00% | 3.89% | CBRE |
| Free Cash Flow (TTM) | $47.69M | $1.40B | CBRE |
| 1-Year Return | -28.42% | 42.57% | CBRE |
| Price-to-Sales Ratio (TTM) | 0.59 | 1.29 | Real Brokerage |
| Enterprise Value | $814.05M | $51.42B | CBRE |
| EV/Revenue Ratio | 0.57 | 1.40 | Real Brokerage |
| Gross Profit Margin (TTM) | 9.59% | 18.46% | CBRE |
| Revenue per Share (TTM) | $7 | $121 | CBRE |
| Earnings per Share (Diluted) | $-0.07 | $3.27 | CBRE |
| Beta (Stock Volatility) | 1.51 | 1.30 | CBRE |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Real Brokerage vs CBRE Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Real Brokerage | -2.45% | -7.87% | -11.75% | -9.75% | -22.72% | -13.48% |
| CBRE | -0.43% | 8.81% | 12.31% | 28.80% | 8.79% | 21.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Real Brokerage | -28.42% | 160.13% | 391.36% | 391.36% | 391.36% | 391.36% |
| CBRE | 42.57% | 87.41% | 257.50% | 320.10% | 827.34% | 907.49% |
Performance & Financial Health Analysis: Real Brokerage vs CBRE
| Metric | REAX | CBRE |
|---|---|---|
| Market Information | ||
| Market Cap | $841.30M | $47.41B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 930,470 | 1,296,070 |
| 90 Day Avg. Volume | 1,020,367 | 1,368,883 |
| Last Close | $3.98 | $157.37 |
| 52 Week Range | $3.80 - $6.75 | $105.17 - $161.03 |
| % from 52W High | -41.04% | -2.27% |
| All-Time High | $6.75 (Aug 19, 2024) | $161.05 (Jul 29, 2025) |
| % from All-Time High | -41.04% | -2.29% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.76% | 0.12% |
| Quarterly Earnings Growth | 0.76% | 0.29% |
| Financial Health | ||
| Profit Margin (TTM) | -0.01% | 0.03% |
| Operating Margin (TTM) | -0.01% | 0.03% |
| Return on Equity (TTM) | -0.53% | 0.12% |
| Debt to Equity (MRQ) | 0.00 | 100.42 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $0.16 | $28.06 |
| Cash per Share (MRQ) | $0.17 | $4.71 |
| Operating Cash Flow (TTM) | $43.20M | $1.65B |
| Levered Free Cash Flow (TTM) | $44.27M | $1.16B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Real Brokerage vs CBRE
| Metric | REAX | CBRE |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -28.43 | 48.64 |
| Forward P/E | -102.00 | 26.51 |
| PEG Ratio | -102.00 | 26.51 |
| Price to Sales (TTM) | 0.59 | 1.29 |
| Price to Book (MRQ) | 25.50 | 5.67 |
| Market Capitalization | ||
| Market Capitalization | $841.30M | $47.41B |
| Enterprise Value | $814.05M | $51.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.57 | 1.40 |
| Enterprise to EBITDA | -61.35 | 22.79 |
| Risk & Other Metrics | ||
| Beta | 1.51 | 1.30 |
| Book Value per Share (MRQ) | $0.16 | $28.06 |
Financial Statements Comparison: Real Brokerage vs CBRE
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | REAX | CBRE |
|---|---|---|
| Revenue/Sales | $353.98M | $8.91B |
| Cost of Goods Sold | $320.05M | $7.27B |
| Gross Profit | $33.94M | $1.65B |
| Research & Development | $3.93M | N/A |
| Operating Income (EBIT) | $-5.21M | $276.00M |
| EBITDA | $-4.83M | $453.00M |
| Pre-Tax Income | $-5.12M | $243.00M |
| Income Tax | N/A | $52.00M |
| Net Income (Profit) | $-5.12M | $191.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | REAX | CBRE |
|---|---|---|
| Cash & Equivalents | $24.71M | $1.38B |
| Total Current Assets | $83.90M | $10.83B |
| Total Current Liabilities | $67.94M | $10.87B |
| Long-Term Debt | N/A | $5.15B |
| Total Shareholders Equity | $32.52M | $8.63B |
| Retained Earnings | $-109.71M | $9.39B |
| Property, Plant & Equipment | N/A | $4.74B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | REAX | CBRE |
|---|---|---|
| Operating Cash Flow | $8.08M | $329.00M |
| Capital Expenditures | $-285,000 | N/A |
| Free Cash Flow | $15.67M | $-610.00M |
| Debt Repayment | N/A | $-165.00M |
| Common Stock Repurchase | $-6.12M | $-418.00M |
Short Interest & Institutional Ownership Analysis
| Metric | REAX | CBRE |
|---|---|---|
| Shares Short | 2.38M | 3.69M |
| Short Ratio | 2.05 | 2.62 |
| Short % of Float | N/A | 0.01% |
| Average Daily Volume (10 Day) | 930,470 | 1,296,070 |
| Average Daily Volume (90 Day) | 1,020,367 | 1,368,883 |
| Shares Outstanding | 202.50M | 302.05M |
| Float Shares | 155.48M | 291.46M |
| % Held by Insiders | 0.19% | 0.01% |
| % Held by Institutions | 0.43% | 1.00% |
Dividend Analysis & Yield Comparison: Real Brokerage vs CBRE
| Metric | REAX | CBRE |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |